arrow
P

Petri Bono

Fahrenheit universities
H指数:53
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PRELIMINARY EFFICACY OF BEXMARILIMAB WITH AZACITIDINE IN RELAPSED OR REFRACTORY MDS IN BEXMAB PH1/2 STUDY

BEXMAB PH1/2研究中,培克马利姆单抗联合阿扎胞苷治疗复发或难治性MDS的初步疗效

2025-09-010
PRE
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial
2023-12-017
OAAI
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer
2023-10-260
OAAI
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma

促血管生成单核细胞的减少可预测转移性肾细胞癌患者抗血管生成治疗的临床反应

CELLS
IF5.2
2021-12-226
OAAI
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

转移性肾细胞癌nivolumab-ipilimumab失败后的二线靶向治疗

2019-02-01103
PREAI